Birdwatch Archive

Birdwatch Note Rating

2024-01-15 02:49:42 UTC - NOT_HELPFUL

Rated by Participant: E7B3E2F8D7D4D4C36D0C99B9D43D0999B80B7CCF57E4B2126C0E84EE23BEF803
Participant Details

Original Note:

False claim. Vivek Ramaswamy owns a 7% stake in Roivant Sciences. Roivants financial interests in lipid nanoparticle delivery systems are publicly available in legal filings. Patent litigation involving Genevant/Roivant and Moderna are pending. https://investor.roivant.com/static-files/a7b36392-1f44-4251-87cf-8dd572f3034e https://www.fiercepharma.com/pharma/pandemic-patent-fights-continue-arbutus-genevant-coming-after-pfizer-and-biontech-new-suit

All Note Details

Original Tweet

All Information

  • noteId - 1746676161839607928
  • participantId -
  • raterParticipantId - E7B3E2F8D7D4D4C36D0C99B9D43D0999B80B7CCF57E4B2126C0E84EE23BEF803
  • createdAtMillis - 1705286982942
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1746676161839607928E7B3E2F8D7D4D4C36D0C99B9D43D0999B80B7CCF57E4B2126C0E84EE23BEF803